Cetuximab inhibits oral squamous cell carcinoma invasion and metastasis via degradation of epidermal growth factor receptor

pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma

(2012) Gabriella Aquino et al.   CANCER BIOLOGY & THERAPY

Palliative weekly chemotherapy along with cetuximab in recurrent and metastatic head and neck cancers: A retrospective analysis

(2012) RR Rangaraju et al.   INDIAN JOURNAL OF CANCER

Serum biomarker modulation following molecular targeting of epidermal growth factor and cyclooxygenase pathways: A pilot randomized trial in head and neck cancer

(2012) Howard S. Moskowitz et al.   ORAL ONCOLOGY

Topical Polyethylene Glycol as a Novel Chemopreventive Agent for Oral Cancer via Targeting of Epidermal Growth Factor Response

(2012) Ramesh K. Wali et al.   PLoS One

Hypoxia Activated EGFR Signaling Induces Epithelial to Mesenchymal Transition (EMT)

(2012) Ashish Misra et al.   PLoS One

Cetuximab therapy in head and neck cancer: Immune modulation with interleukin-12 and other natural killer cell–activating cytokines

(2012) Eric Luedke et al.   SURGERY

EGFR gene copy number alteration is a better prognostic indicator than protein overexpression in oral tongue squamous cell carcinomas

(2011) Yoshimi Nakata et al.   EUROPEAN JOURNAL OF CANCER

Quantitative Chemical Proteomics Reveals New Potential Drug Targets in Head and Neck Cancer

(2011) Zhixiang Wu et al.   MOLECULAR & CELLULAR PROTEOMICS

Overexpression of Integrin β5 Enhances the Paracrine Properties of Circulating Angiogenic Cells via Src Kinase–Mediated Activation of STAT3

(2010) Maren Leifheit-Nestler et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

HGF Rescues Colorectal Cancer Cells from EGFR Inhibition via MET Activation

(2010) D. Liska et al.   CLINICAL CANCER RESEARCH

The Effect of Combination Anti–Endothelial Growth Factor Receptor and Anti–Vascular Endothelial Growth Factor Receptor 2 Targeted Therapy on Lymph Node Metastasis

(2009) Daisuke Sano et al.   ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY

Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells

(2009) Angel Ayuso-Sacido et al.   JOURNAL OF NEURO-ONCOLOGY

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

(2009) James A Bonner et al.   LANCET ONCOLOGY